NCT07400458招募中不适用
Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration to Evaluate Its Safety in Patients With Acute Myocardial Infarction
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Rate of AESI
研究概览
简要总结
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
详细描述
To evaluate the safety for 60 months after a single dose of Hearticellgram-AMI in patients with Acute Myocardial Infarction.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Those who had administered Hearticellgram-AMI
- •Those who voluntarily agreed in writing to participate in this investigation
排除标准
- 未提供
研究组 & 干预措施
Hearticellgram-AMI
Experimental
Patients with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
干预措施: Hearticellgram-AMI (Biological)
结局指标
主要结局
Rate of AESI
时间窗: For 5 years
death, neoplasms or malignancies in tissues or organs, Immune response
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial InfarctionAMIMyocardial InfarctionNCT07362446Nyrada Pty Ltd300
Enrolling By Invitation
不适用
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDNHypertensionNCT07273877Shanghai Golden Leaf MedTec Co. Ltd1,000
招募中
2 期
A prospective randomized, single-blind, multicenter phase II study comparing two methods of cardioplegia in cardiac surgery due to congenital heart malformation in children:
Custodiol-N versus Custodiol (CL-N-CP-Paed-II/09/19)2024-511517-38-00Dr. Franz Koehler Chemie GmbH100
招募中
不适用
Incidence of Long-TeRm Atrial Fibrillation After Acute IllnessNCT07434674University of California, San Diego100
已完成
2 期
LONG-TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AND COMPARISON WITH AN UNTREATED COHORT OF CHILDREN WITH PRADER-WILLI SYNDROME
(OTBB3 FOLLOW-UP)2024-517925-25-00Centre Hospitalier Universitaire De Toulouse65